• Nem Talált Eredményt

18 eredmény a kulcsszóra: 'hepatocellular carcinoma hcc'

Study on factors of vitamin D metabolism in hepatocellular carcinoma

Comparison of VDR, CYP27B1, and CYP24A1 mRNA expression profile in hepatocellular carcinoma (HCC) with surrounding non-tumorous liver tissue samples.. Comparison of

Protected

N/A

19
0
0
2022
DEVELOPMENT OF BIOCONJUGATES AND THEIR MODUL CONSTRUCTS FOR TARGETED THERAPY OF CANCERS WITH HIGH MORTALITY

5,6 Ferrocene  cinchona hybrids with triazolyl-chalcone linkers showed a marked anti-tumor effect on HT-29 human colon carcinoma and HepG2 human hepatocellular carcinoma 6

Protected

N/A

6
0
0
2022
25th International Symposium on Analytical and Environmental Problems

The noncovalent interaction between the Amyloid beta (Aβ) protein and a native complex mixture of gangliosides extracted and purified from normal adult human

Protected

N/A

1
0
0
2022
Ágnes Holczbauer, M.D. Pathology Doctoral School Semmelweis University

Human hepatocellular carcinoma and liver metastases of colorectal adenocarcinoma and pancreatic adenocarcinoma display distinct claudin expression profiles: HCCs

Protected

N/A

136
0
0
2022
Nem alkoholos zsírmájbetegség – a 2016. évi közös EASL–EASD–EASO klinikai ajánlás fényében

A magas prevalencia mellett a NAFLD jelentőségét a spektrumbetegség (steatosis → NASH [nem alkoholos steatohepatitis] ± fibrosis → cirrhosis → HCC [hepatocellularis

Protected

N/A

16
0
0
2022
Claudin-7 protein differentiates caninecholangiocarcinoma from hepatocellular carcinoma

Methods and results: Necropsy samples included 15 canine normal liver tissue samples, 10 hepatocellular nodular hyperplasias, 6 hepatocellular adenomas, 15 well-differentiated and

Protected

N/A

8
0
0
2022
A MAGYAR OKTATÓ MESE TÖRTENETE 1786-TÓL 1807-IG. (Második és befejező közlemény.)

(Pechata János) adja ki újból meséit és más verseit. század első évtizedének oktató meséire, meg kell emlékeznünk még két költőnkről, kiknek művei értékesebbek

Protected

N/A

11
0
0
2022
Cholangiocarcinoma in Wilson’s Disease – a Case Report

The presented case argues that cholangiocarcinoma may develop in well-treated Wilson’s disease patients, on a cirrohic liver, similarly to hepatocellular carcinoma.. The curiosity of

Protected

N/A

4
0
0
2022
Libyan medicinal plants and their cytotoxic compounds

Various extracts of these plants were screened for their cytotoxicity against five human cancer cell lines: urinary bladder cancer (EJ-138), liver hepatocellular carcinoma

Protected

N/A

1
0
0
2022
Prosodic boundaries in Hungarian infant-directed speech ´Ad´am Szalontai

The parameters used in the analysis were the duration of the vowel /a/ in the final syllable of the target word normalised to the initial syllable of the target word /la:tlak/,

Protected

N/A

2
0
0
2022
2-es típusú diabetes mellitus, inzulinrezisztencia és májrák idült hepatitis C-fertőzésben

Hb = hemoglobin; HbA 1c = hemoglobin-A-1c; HCC = (hepa- tocellular carcinoma) májrák; HCV = hepatitis C-vírus; HCV- RNS = hepatitis C-vírus-ribonukleinsav; HDL = (high-density

Protected

N/A

12
0
0
2022
Cecília Franchini LA GENERAZIONE DELL’OTTANTA; UNO SGUARDO A CASELLA E MALIPIERO

Alcuni di questi m usicistispecialm ente Malipiero e Pizzetti - si rivolsero invece al canto gregoriano, come a una spécié di sepolta coscienza musicále della

Protected

N/A

8
0
0
2022
Development of Highly Efficient, Glassy Carbon Foam Supported, Palladium Catalysts for Hydrogenation of Nitrobenzene

The particle size distribution in the case of the Pd/GCF and the Pd/GCF-AC1 catalysts was similar (Figure 2D), despite the varying BET surface area (370 and 2172 m 2 /g,

Protected

N/A

13
0
0
2022
Now, I will be the storyteller

Developing children are sensitive to this kind of contigent reactivity, which makes it possible for them to be able to differentiate between the ostensive

Protected

N/A

2
0
0
2022
A multi-layered phase field model for extracting near-circular shapes

 The properties of the model in the case of two circles with different levels of overlap and different strength of penalty.  There is a competition between the data term and

Protected

N/A

1
0
0
2022
Recurrent diseases following orthotopic liver transplantation

Nemes B, Gelley F, Zádori G, Görög D, Fehérvári I, Kóbori L, Sárváry E, Nagy P, Kiss A, Doros A.: The impact of milan criteria on liver transplantation for

Protected

N/A

16
0
0
2022
ACTING  UPON  SLIDCE  GATES

Although this latter method is based upon much more correct boundary conditions than that of Kulka, one ·will find that the difference between values calculated from

Protected

N/A

6
0
0
2022

Töltsön fel további dokumentumokat, és töltse le azonnal az anyagtanulmányokat!